The United States Court of Appeals for the Second Circuit has upheld the convictions of Ikechukwu Udeokoro and Ayodeji Fasonu for health care fraud. The court's decision, issued on November 16, 2026, confirms that the defendants engaged in fraudulent billing practices while operating a medical supply company. This ruling impacts Udeokoro and Fasonu, who were sentenced to time served and must pay substantial restitution and forfeiture.

The case centers on the operations of Meik Medical Equipment and Supply, LLC, where Udeokoro served as president and Fasonu as business manager. The defendants were found guilty of submitting false claims to Medicare and Medicaid by billing for expensive medical devices while providing much cheaper equipment. The court's ruling clarifies the legal boundaries regarding evidentiary rulings in fraud cases and underscores the importance of intent in such prosecutions.

Udeokoro and Fasonu's appeal stemmed from their convictions for health care fraud, specifically violations of 18 U.S.C. § 1347. The defendants argued that the district court improperly excluded certain evidence and testimony that could have supported their defense. They contended that third-party billing intermediaries did not correct the inaccurate codes submitted by them, which they claimed suggested they acted in good faith. The district court had previously sentenced both defendants to time served, followed by two years of supervised release, and ordered them to pay restitution and forfeiture.

The case reached the Second Circuit after Udeokoro and Fasonu filed their appeal against the judgments of the district court for the Eastern District of New York. The defendants sought to overturn their convictions, claiming violations of their constitutional rights to present a complete defense. They argued that the exclusion of certain testimony prevented them from adequately demonstrating their good faith in the billing practices.

The court ruled that the district court's decisions regarding the admissibility of evidence were within the permissible range of judicial discretion. The judges noted that the defendants had opportunities to present their defense and that the excluded evidence did not significantly impact the case. The opinion stated, "Whether the IPAs caught the [defendants’] misrepresentations, or even tacitly approved of them, is not relevant to what the defendants knew or intended in making those misrepresentations."

The court affirmed the lower court's findings, emphasizing that the defendants' actions were central to the case. The judges ruled that the exclusion of the testimony regarding the intermediaries did not violate the defendants' rights to present a complete defense. The court highlighted that the defendants were allowed to present evidence that they received instructions from insurers and intermediaries regarding billing codes.

This ruling has significant implications for similar cases in the future. It reinforces the principle that defendants in fraud cases must demonstrate their intent and knowledge regarding the fraudulent activities. The court's decision clarifies that merely relying on the actions or omissions of third parties does not absolve defendants of responsibility for their actions. The ruling may influence how future health care fraud cases are prosecuted and defended, particularly regarding the admissibility of evidence related to third-party conduct.

The court's decision to affirm the convictions indicates a strong stance against health care fraud and emphasizes the importance of accountability in the medical supply industry. This case serves as a reminder to medical providers about the legal obligations they have when billing insurers and the potential consequences of fraudulent practices.

As for what’s next, Udeokoro and Fasonu have the option to seek further appeals, although the court's ruling stands as a significant legal precedent. There are no related cases pending that have been mentioned in the court filing. The defendants will need to comply with the terms of their sentencing, which includes supervised release and financial restitution.